Clinical Trial Update: GCC19CART for Patients With Metastatic Colorectal Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for GCC19CART in metastatic colorectal cancer shows the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• GCC19CART

Snippet

Sponsor: Lyell Immunopharma, Inc. | Conditions: Colorectal Cancer | Phase 1 | Status: RECRUITING